Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASPOFUNGIN vs CEFEPIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASPOFUNGIN vs CEFEPIME: Safety Overview

Metric CASPOFUNGIN CEFEPIME
Total FAERS Reports 3,814 5,540
Deaths Reported 1,419 997
Death Rate 37.2% 18.0%
Hospitalizations 1,638 3,055
Average Patient Age 47.5 yrs 56.5 yrs
% Female Patients 42.8% 47.6%
FDA Approval Date Dec 30, 2016 Aug 21, 2018
Manufacturer Sandoz Inc Apotex Corp.
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Discontinued Discontinued